ResearcherUniversitätsmedizin GöttingenNo recent work listed

Jeannine Missbach‐Guentner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1033-8403; OpenAlex author ID A5043359961. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography - the next dimension of diagnosis. Last author DOI 10.1186/s40644-023-00559-6 ↗
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma. Co-author DOI 10.1038/s41467-021-21774-4 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Diana Pinkert‐Leetsch · 2 shared papers, 2021–2023 · strength 0.32
- Paper Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography - the next dim… DOI 10.1186/s40644-023-00559-6 ↗
- Paper Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenoca… DOI 10.1038/s41467-021-21774-4 ↗
Frauke Alves · 2 shared papers, 2021–2023 · strength 0.32
- Paper Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography - the next dim… DOI 10.1186/s40644-023-00559-6 ↗
- Paper Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenoca… DOI 10.1038/s41467-021-21774-4 ↗
Janina Henze · 1 shared paper, 2021 · strength 0.10
- Paper Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenoca… DOI 10.1038/s41467-021-21774-4 ↗
Wa’el Al Rawashdeh · 1 shared paper, 2021 · strength 0.10
- Paper Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenoca… DOI 10.1038/s41467-021-21774-4 ↗
Olaf Hardt · 1 shared paper, 2021 · strength 0.10
- Paper Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenoca… DOI 10.1038/s41467-021-21774-4 ↗
Daniel Schaefer · 1 shared paper, 2021 · strength 0.10
- Paper Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenoca… DOI 10.1038/s41467-021-21774-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.